ID
42598
Beskrivning
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the Significant Medical/ Surgical History And Physical Examination and the Prior Medication form. It has to be filled in for screening.
Nyckelord
Versioner (4)
- 2017-09-01 2017-09-01 -
- 2019-06-18 2019-06-18 -
- 2019-06-18 2019-06-18 -
- 2021-09-17 2021-09-17 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
17 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Significant Medical/ Surgical History And Physical Examination, Prior Medication
Beskrivning
Significant Medical/ Surgical History And Physical Examination
Alias
- UMLS CUI-1
- C0262926
- UMLS CUI-2
- C0031809
Beskrivning
If you tick Yes, fill in the follwoing items for each diagnosis. Only in the absence of a diagnosis, record the signs and symptoms on separate lines.
Datatyp
text
Alias
- UMLS CUI [1]
- C1699700
- UMLS CUI [2]
- C0543467
Beskrivning
Diagnosis
Datatyp
text
Alias
- UMLS CUI [1]
- C0011900
Beskrivning
Month Year
Datatyp
partialDate
Alias
- UMLS CUI [1,1]
- C0439234
- UMLS CUI [1,2]
- C0011900
Beskrivning
Medical condition
Datatyp
text
Beskrivning
Prior Medication
Alias
- UMLS CUI-1
- C2826257
Beskrivning
If you tick ‘Yes’, please record each medication in the following items.
Datatyp
text
Alias
- UMLS CUI [1]
- C2826257
Beskrivning
(Trade name preferred)
Datatyp
text
Alias
- UMLS CUI [1]
- C2360065
Beskrivning
(eg 500 mg)
Datatyp
text
Alias
- UMLS CUI [1]
- C1960417
Beskrivning
(eg BID, PRN)
Datatyp
text
Alias
- UMLS CUI [1]
- C3476109
Beskrivning
Other routes may be entered onto the form when appropriate, and will be coded prior to data entry.
Datatyp
text
Alias
- UMLS CUI [1]
- C0013153
Beskrivning
Indication on Prior Medication page must correlate utilizing the same terminology. Indication on Concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology.
Datatyp
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Beskrivning
(e.g. 6 years)
Datatyp
text
Alias
- UMLS CUI [1]
- C0444921
Beskrivning
day month year. If therapy/medication is continuing tick the follwing item.
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [2,1]
- C0013227
- UMLS CUI [2,2]
- C0806020
Beskrivning
If a medication was marked continuing at the initial visit (on the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
Datatyp
text
Alias
- UMLS CUI [1]
- C1553904
Similar models
Significant Medical/ Surgical History And Physical Examination, Prior Medication
C0031809 (UMLS CUI-2)
C0543467 (UMLS CUI [2])
C0011900 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0806020 (UMLS CUI [2,2])
Inga kommentarer